Showing results (1591-1600 of 2,171) with videos related to
Sort By:
Pageof 218
The American Journal of Medicine|June 6, 1994
Treatment of primary hypercholesterolemia: fluvastatin versus bezafibrateH Greten, F U Beil, J Schneider, et al.Journal of Pharmaceutical and Biomedical Analysis|April 7, 2018
Effective methodologies for enantiomeric separations of 150 pharmacology and toxicology related 1°, 2°, and 3° amines with core-shell chiral stationary phasesGarrett Hellinghausen, Daipayan Roy, Jauh T Lee, et al.European Heart Journal. Acute Cardiovascular Care|June 20, 2017
Relationship between community hospital versus pre-hospital location of randomisation and clinical outcomes in ST-elevation myocardial infarction patients: insights from the Stream studyRobert C Welsh, Patrick Goldstein, Peter Sinnaeve, et al.The Journal of Rheumatology. Supplement|June 2, 2021
Report of the Skin Research Working Groups From the GRAPPA 2020 Annual MeetingLourdes M Perez-Chada, Alison Kohn, Alice B Gottlieb, et al.Dermatology (Basel, Switzerland)|August 20, 2018
Are Your Patients Satisfied A Systematic Review of Treatment Satisfaction Measures in PsoriasisNicole Salame, Lourdes M Perez-Chada, Sanminder Singh, et al.Photochemistry and Photobiology|June 12, 2004
The complex of apomyoglobin with the fluorescent dye coumarin 153P K Chowdhury, M Halder, L Sanders, et al.JAMA Dermatology|January 19, 2022
Analysis of Specialist and Patient Perspectives on Strategies to Improve Cardiovascular Disease Prevention Among Persons With Psoriatic DiseaseJohn S Barbieri, Rinad S Beidas, George C Gondo, et al.The Journal of Investigative Dermatology|June 18, 2019
Guselkumab Efficacy after Withdrawal Is Associated with Suppression of Serum IL-23-Regulated IL-17 and IL-22 in Psoriasis: VOYAGE 2 StudyKenneth B Gordon, April W Armstrong, Peter Foley, et al.Chemical Communications (Cambridge, England)|February 1, 2006
Do ion tethered functional groups affect IL solvent properties? The case of sulfoxides and sulfonesNawal K Sharma, Morgan D Tickell, Jared L Anderson, et al.Expert Opinion on Investigational Drugs|November 1, 2005
MC-1 (pyridoxal 5'-phosphate): novel therapeutic applications to reduce ischaemic injuryDavid E Kandzari, Jean-Pierre Dery, Paul W Armstrong, et al.Pageof 218